takeda pharmaceutical co
Takeda Pharma To Acquire Envoy Therapeutics
Takeda’s subsidiary, Takeda America Holdings is set to acquire Envoy for up to US$140 million in cash.
Takeda To Acquire Vaccine Maker LigoCyte Pharma For US$60m
Takeda Pharma will acquire LigoCyte Pharmaceuticals for an upfront payment of US$60 million, it announced on Friday.
Lotriga 2g Receives NDA Approval In Japan For Hyperlipidemia
The Japanese Ministry of Health, Labor and Welfare has approved a New Drug Application of Lotriga granular capsule 2g for the treatment of hyperlipidemia in Japan.
Takeda Initiates Phase 3 Trial For Lung Cancer Drug
Takeda Pharma announced yesterday the initiation of a Phase 3 clinical trial involving 400 patients across Japan, Hong Kong, South Korea, and Taiwan.
Takeda Unveils New Treatment For Hypertension In Japan
AZILVA, a new drug from Takeda Pharmaceutical Company Limited, is now available for the treatment of hypertension in Japan.
Takeda To Acquire Brazil’s Multilab For US$250 Million
Takeda Farmacêutica Brasil Ltda., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, is set to acquire Brazil-based Multilab for US$250 million.
Takeda To Acquire URL Pharma For Gout Drug, Colcrys
Takeda Pharma subsidiary Takeda America Holdings, Inc. is set to acquire Philadelphia-based URL Pharma for US$800 million.
Takeda Joins International Open-Source Drug Research Consortium
Takeda Pharma has joined the Structural Genomics Consortium to fund collective drug research aimed at bringing new, more effective medicines to market faster.
Millennium Initiates Phase III Trial On Peripheral T-Cell Lymphoma Drug
Millennium today announced the initiation of an international Phase III clinical trial evaluating MLN8237 in patients with relapsed or refractory peripheral T-cell lymphoma.
